MedTrace Logo

Iron Depletion and Replacement in Blood Donors

NCT01752413 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 197

Last updated 2021-09-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine (1) the role of ferritin testing to screen for iron depletion in donors at risk of low iron levels (2) the effectiveness of oral iron replacement therapy on the repletion of iron stores in donors, and (3) the feasibility of blood centers to routinely distribute oral iron replacement therapy to donors.

Conditions

Interventions

DIETARY_SUPPLEMENT

Ferrous gluconate 325mg

Participants with low ferritin (\<30 micrograms/L (males) or \<20 micrograms/L (females)) will be asked to take two tablets of Ferrous Gluconate 325 mg (36 mg elemental iron) per day.

BEHAVIORAL

Nutrition counseling

All blood donors receive current dietary counseling recommending iron rich foods

Sponsors & Collaborators

  • Memorial Blood Centers, Minnesota

    lead OTHER

Principal Investigators

  • Jed B. Gorlin, MD, MBA · Memorial Blood Centers

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01752413 on ClinicalTrials.gov